Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|March 24, 2026
A phantom study to achieve comparable 124I PET recovery and address scanner variability for dosimetry purposes in (re)differentiated thyroid cancerMaaike Dotinga, Lioe-Fee de Geus-Oei, Petra Dibbets-Schneider, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 15, 2025
No reinduction of clinically relevant radioiodine uptake after lenvatinib treatment in radioidine-refractory differentiated thyroid cancerMaaike Dotinga, Lioe-Fee de Geus-Oei, Floris H P van Velden, et al.
Diagnostics (Basel, Switzerland)|December 23, 2022
Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II TrialMaaike Dotinga, Dennis Vriens, Floris H P van Velden, et al.
EJNMMI Research|March 7, 2022
Feasibility of fluorescence imaging at microdosing using a hybrid PSMA tracer during robot-assisted radical prostatectomy in a large animal modelPaolo Dell'Oglio, Danny M van Willigen, Matthias N van Oosterom, et al.
Molecular Imaging and Biology|August 24, 2022
Cysteine Cathepsins in Breast Cancer: Promising Targets for Fluorescence-Guided SurgeryDaan G J Linders, Okker D Bijlstra, Laura C Fallert, et al.
Oncogene|October 12, 2018
Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibitionH Rudolf de Boer, Martin Pool, Esméé Joosten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2016
Biodistribution and PET Imaging of Labeled Bispecific T Cell-Engaging Antibody Targeting EpCAMFrank J Warnders, Stijn J H Waaijer, Martin Pool, et al.
Molecular Imaging and Biology|September 27, 2024
Immunohistochemical Evaluation of Cathepsin B, L, and S Expression in Breast Cancer PatientsDaan G J Linders, Okker D Bijlstra, Laura C Fallert, et al.
BMJ Open|April 8, 2026
[89Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic NF2-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trialJules P J Douwes, Annemijn L Tops, Petra Dibbets-Schneider, et al.
Pharmacological Research|October 14, 2024
Ex vivo fluorescence-guided resection margin assessment in breast cancer surgery using a topically applied, cathepsin-activatable imaging agentDaan G J Linders, Okker D Bijlstra, Ethan Walker, et al.
Pageof 3